Patent 7780969 was granted and assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. on August, 2010 by the United States Patent and Trademark Office.
Molecular targets are identified in T. cruzi suitable for use in diagnosis of Chagas disease, drug development, and vaccines, including live vaccines.